307 related articles for article (PubMed ID: 16641880)
1. Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma.
Alici S; Kaya S; Izmirli M; Tuncer I; Doğan E; Ozbek H; Sayarlioglu H
Med Sci Monit; 2006 May; 12(5):CR221-9. PubMed ID: 16641880
[TBL] [Abstract][Full Text] [Related]
2. Survival analysis after surgical treatment of gastric cancer: review of 121 cases.
Nazli O; Derici H; Tansug T; Yaman I; Bozdag AD; Isgüder AS; Bölükbasi H
Hepatogastroenterology; 2007 Mar; 54(74):625-9. PubMed ID: 17523337
[TBL] [Abstract][Full Text] [Related]
3. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of tumor size in the survival of patients with advanced gastric carcinoma].
Díaz Plasencia JA; Yan-Quiroz EF; Burgos-Chávez OA; Santillán-Medina JP; Stewart-Vilela Guillén E; Rojas-Vergara AM
Rev Gastroenterol Peru; 2001; 21(1):21-9. PubMed ID: 12170283
[TBL] [Abstract][Full Text] [Related]
6. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
7. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
9. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
10. Significant prognostic factors in patients with node-negative gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 1999; 84(4):331-6. PubMed ID: 10667813
[TBL] [Abstract][Full Text] [Related]
11. [Morbidity and mortality in gastric cancer surgery--analysis of 468 cases with gastric adenocarcinoma].
Necula A; Vlad L; Iancu C; Munteanu D; Puia C; Bălă O; AlHajaar N; Pop F; Radu H; Osian G; Graur F; Furcea L; Stanca M; Molnar G; Mocanu L
Chirurgia (Bucur); 2008; 103(5):529-37. PubMed ID: 19260628
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection.
Sánchez-Bueno F; Garcia-Marcilla JA; Perez-Flores D; Pérez-Abad JM; Vicente R; Aranda F; Ramirez P; Parrilla P
Br J Surg; 1998 Feb; 85(2):255-60. PubMed ID: 9501830
[TBL] [Abstract][Full Text] [Related]
13. Palliative surgery for advanced stage (stage IV) gastric adenocarcinoma.
Nazli O; Yaman I; Tansuğ T; Işgüder AS; Bozdag AD; Bölükbaşi H
Hepatogastroenterology; 2007; 54(73):298-303. PubMed ID: 17419279
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
[TBL] [Abstract][Full Text] [Related]
15. [Five-year survival prognosis factors in patients with resectable advanced serosa exposed gastric carcinoma].
Yan-Quiroz EF; Díaz-Plasencia JA; Burgos-Chávez OA; Rojas-Vergara AM; Santillán-Medina J; Vilela-Guillén ES; Balmaceda-Fraselle T
Rev Gastroenterol Peru; 2003; 23(3):184-91. PubMed ID: 14532919
[TBL] [Abstract][Full Text] [Related]
16. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
17. Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma.
Borch K; Jönsson B; Tarpila E; Franzén T; Berglund J; Kullman E; Franzén L
Br J Surg; 2000 May; 87(5):618-26. PubMed ID: 10792320
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
[TBL] [Abstract][Full Text] [Related]
19. Surgery for patients with gastric cancer in the terminal stage of the illness - TNM stage IV.
Budisin NI; Majdevac IZ; Budisin ES; Manic D; Patrnogic A; Radovanovic Z
J BUON; 2009; 14(4):593-603. PubMed ID: 20148448
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of patients with resection of stage IV gastric cancer.
Murata S; Terata N; Eguchi Y; Tani T; Shibata J; Kodama M
Int Surg; 1998; 83(4):283-6. PubMed ID: 10096742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
